Certain A Shares of Hangzhou Biotest Biotech Co.,Ltd. are subject to a Lock-Up Agreement Ending on 8-SEP-2022.
September 07, 2022
Share
Certain A Shares of Hangzhou Biotest Biotech Co.,Ltd. are subject to a Lock-Up Agreement Ending on 8-SEP-2022. These A Shares will be under lockup for 370 days starting from 3-SEP-2021 to 8-SEP-2022.
Details:
The shareholders, Chen Yinlong and actual controller and director Chen Yujie, Yu Xiuping, Hangzhou Tuokang Investment Co., Ltd., Hangzhou Kangyu Enterprise Management Consulting Partnership (Limited Partnership), Wu Shujiang, Gao Hongmei, director and senior management of the company, and Song Zhenjin have agreed not to dispose off any shares within 36 months since the listing date. If, within 6 months after the issuer's listing, the closing price of the shares is lower than issuance price for 20 consecutive trading days or if trading price is lower than issuance price after 6 month from listing, lock-up period will be automatically extended for another 6 months.
The shareholders, Ningbo Songling Investment Partnership (Limited Partnership), Du Jianli, Li Honghe, Li Qifu, Li Xujun, Liang Rongwei, Wang Liping, Wang Weihong, Wu Haijiang, Zheng Gangwu and Zhu Aiju have agreed not to dispose off any shares within 12 months since the listing date. If, within 6 months after the issuer's listing, the closing price of the shares is lower than issuance price for 20 consecutive trading days or if trading price is lower than issuance price after 6 month from listing, lock-up period will be automatically extended for another 6 months.
Hangzhou Biotest Biotech Co Ltd is a company mainly engaged in the research and development (R&D), production and sales of point-of-care testing (POCT) diagnostic reagents. The Company's products include reproductive health testing series, such as human chorionic gonadotropin testing reagent and luteinizing hormone testing reagent, and drug abuse testing series, such as morphine testing reagent and cocaine testing reagent, and infectious disease testing series, such as adenovirus testing reagent and typhoid antibody testing reagent, and tumor marker testing series, such as alpha fetoprotein detection reagent, and myocardial marker detection series, such as dimer detection reagent and myocardial series detection reagent.
HANGZHOU BIOTEST BIOTECH CO.,LTD. 
